b'LabPMM Testing Services LabPMM LocationsLABPMM SPECIALIZES IN PERSONALIZED CRO Services MOLECULAR TESTING SERVICES FOR ONCOLOGY, INCLUDING LEUKEMIA AND LYMPHOMA. WE ARE COMMITTED SAN DIEGO, CA, UNITED STATESGlobal Stratification & enrollment of patients in clinical trialsTO PROVIDING HIGH-QUALITY TESTING IN SUPPORT OF PERSONALIZEDMOLECULAR MEDICINE. Diagnostic testing, Research & DevelopmentOur diagnostic and research portfolio includes a full range of oncology services, such as single gene assays for FLT3, NPM1, clonality testing Worldwide experts in precision medicine and companion of B- and T-cells, minimal residual disease (MRD) assessments and diagnostics (CDx) of hematological malignancies. comprehensive next-generation sequencing (NGS) gene panels for AML and other hematologic malignancies. Rapid turnaround times are vital to ensure that the physician canHALBERGMOOS (MUNICH), GERMANYmake timely informed treatment decisions. Our turnaround times for individual gene tests are in the range of 1 to 3 days following sample receipt, while turnaround times for our NGS assays and gene panels LABPMM OFFERS EFFICIENT AND RELIABLE STANDARDIZED TESTS THAT MEETare 5 to 14 days. When using LabPMM, physicians receive results faster THE HIGHEST QUALITY AND SERVICE STANDARDS. which expedites patient care and streamlines clinical trials. The reason is simple: all of our LabPMM sites initiate tests the day of clinical sample receipt, avoiding delays caused by batching of samples for testing.The Laboratories for Personalized Molecular Medicine (LabPMM) is the Invivoscribe global network of clinical reference labsCustomer support is an important aspect of our services. We provide located in the USA, Europe and Asia, which provides international access to harmonized molecular testing.responsive, timely support both via email and telephone. We are also LabPMM specializes in oncology with an emphasis on leukemias and lymphomas. We offer an ever-expanding menubound by strict privacy laws and use only secure proven methodsof molecular assays to support medical diagnosis, research testing, stratification & enrollment of patients in clinical trials,to communicate patient-related data and results.optimization of treatments and development of companion diagnostics (CDx). KAWASAKI (TOKYO), JAPANThe comprehensive test menu is focused on biomarkers that demonstrate clinical utility, providing data and information thatAvailable services include:is clinically actionable and critical to making informed treatment decisions. Our CE-IVD assays and bioinformatics are further developed and manufactured consistently under ISO 13485 in our FDA-registered facility, making them eligible to be submitted to worldwide regulatory authorities for registration. CDx FLT3 LabPMM is one of the only international laboratory networks that offers both flow cytometry and NGS-based MRD testingNGS Gene Panelsfor coherent comparisons for a number of clinically significant biomarkers. Accordingly, test results generated in any of our laboratories in Europe, Asia, or the USA are internationally concordant and reproducible. The harmonized testing provided by LabPMM assists healthcare providers in offering optimized and consistent care for their patients, as the test results accurately Clonality testing (IGH, IGK, TRG & TRB) and reproducibly stratify patients for international clinical trials, thus ensuring that patients receive optimal treatment and that drugs are approved quickly. MRD assaysCustom assays SHANGHAI, CHINAMultiparametric Flow Cytometry2 LabPMM Services Catalog 2021|32'